{"id":31460,"date":"2026-08-24T09:30:28","date_gmt":"2026-08-24T08:30:28","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=31460"},"modified":"2026-08-24T09:31:11","modified_gmt":"2026-08-24T08:31:11","slug":"rapport-de-synthese-sur-leqa-2025-de-lears-net","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/","title":{"rendered":"Rapport de synth\u00e8se sur l\u2019EQA 2025 de l\u2019EARS-Net"},"content":{"rendered":"\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-1 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img fetchpriority=\"high\" decoding=\"async\" width=\"629\" height=\"848\" src=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/08\/Summary-report-on-EARS-Net-EQA-2025.png\" alt=\"\" class=\"wp-image-31461\" style=\"width:338px;height:auto\" srcset=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/08\/Summary-report-on-EARS-Net-EQA-2025.png 629w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/08\/Summary-report-on-EARS-Net-EQA-2025-223x300.png 223w\" sizes=\"(max-width: 629px) 100vw, 629px\" \/><\/figure><\/div><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p>Le 4 juin 2026, le Laboratoire de r\u00e9f\u00e9rence de l\u2019Union europ\u00e9enne pour la sant\u00e9 publique en mati\u00e8re de r\u00e9sistance aux antimicrobiens (EURL-PH-AMR) a publi\u00e9 le \u00ab Rapport de synth\u00e8se sur l\u2019EQA 2025 de l\u2019EARS-Net \u00bb. Ce rapport pr\u00e9sente les r\u00e9sultats de l&#8217;exercice d&#8217;\u00e9valuation externe de la qualit\u00e9 (EQA) de 2025 portant sur les tests de sensibilit\u00e9 aux antimicrobiens (AST) r\u00e9alis\u00e9s par les laboratoires cliniques participant au R\u00e9seau europ\u00e9en de surveillance de la r\u00e9sistance aux antimicrobiens (EARS-Net).<\/p>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-1 wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.ecdc.europa.eu\/en\/news-events\/summary-report-ears-net-eqa-2025-published-european-union-reference-laboratory-public\" target=\"_blank\" rel=\"noreferrer noopener\">Lire le rapport<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Le 4 juin 2026, le Laboratoire de r\u00e9f\u00e9rence de l\u2019Union europ\u00e9enne pour la sant\u00e9 publique en mati\u00e8re de r\u00e9sistance aux antimicrobiens (EURL-PH-AMR) a publi\u00e9 le \u00ab Rapport de synth\u00e8se sur l\u2019EQA 2025 de l\u2019EARS-Net \u00bb. Ce rapport pr\u00e9sente les r\u00e9sultats de l&#8217;exercice d&#8217;\u00e9valuation externe de la qualit\u00e9 (EQA) de 2025 portant sur les tests de [&hellip;]<\/p>\n","protected":false},"author":285,"featured_media":31461,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31,37,26],"tags":[6697,6607,6733,6579,6698],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Rapport de synth\u00e8se sur l\u2019EQA 2025 de l\u2019EARS-Net - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rapport de synth\u00e8se sur l\u2019EQA 2025 de l\u2019EARS-Net - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-24T08:30:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-24T08:31:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/08\/Summary-report-on-EARS-Net-EQA-2025.png\" \/>\n\t<meta property=\"og:image:width\" content=\"629\" \/>\n\t<meta property=\"og:image:height\" content=\"848\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Aurore Brunet\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Aurore Brunet\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/\"},\"author\":{\"name\":\"Aurore Brunet\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6d6eef4984fc1159096f6dd1f6c2ac41\"},\"headline\":\"Rapport de synth\u00e8se sur l\u2019EQA 2025 de l\u2019EARS-Net\",\"datePublished\":\"2026-08-24T08:30:28+00:00\",\"dateModified\":\"2026-08-24T08:31:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/\"},\"wordCount\":100,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/08\/Summary-report-on-EARS-Net-EQA-2025.png\",\"keywords\":[\"AMR\",\"Antibior\u00e9sistance\",\"Antibiotic Resistance\",\"antimicrobial\",\"Antimicrobial Resistance\"],\"articleSection\":[\"Actualit\u00e9s\",\"Bilans, rapports et recommandations\",\"Infos pratiques &amp; communications\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/\",\"name\":\"Rapport de synth\u00e8se sur l\u2019EQA 2025 de l\u2019EARS-Net - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/08\/Summary-report-on-EARS-Net-EQA-2025.png\",\"datePublished\":\"2026-08-24T08:30:28+00:00\",\"dateModified\":\"2026-08-24T08:31:11+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/08\/Summary-report-on-EARS-Net-EQA-2025.png\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/08\/Summary-report-on-EARS-Net-EQA-2025.png\",\"width\":629,\"height\":848},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Rapport de synth\u00e8se sur l\u2019EQA 2025 de l\u2019EARS-Net\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6d6eef4984fc1159096f6dd1f6c2ac41\",\"name\":\"Aurore Brunet\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rapport de synth\u00e8se sur l\u2019EQA 2025 de l\u2019EARS-Net - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/","og_locale":"fr_FR","og_type":"article","og_title":"Rapport de synth\u00e8se sur l\u2019EQA 2025 de l\u2019EARS-Net - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2026-08-24T08:30:28+00:00","article_modified_time":"2026-08-24T08:31:11+00:00","og_image":[{"width":629,"height":848,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/08\/Summary-report-on-EARS-Net-EQA-2025.png","type":"image\/png"}],"author":"Aurore Brunet","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Aurore Brunet"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/"},"author":{"name":"Aurore Brunet","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6d6eef4984fc1159096f6dd1f6c2ac41"},"headline":"Rapport de synth\u00e8se sur l\u2019EQA 2025 de l\u2019EARS-Net","datePublished":"2026-08-24T08:30:28+00:00","dateModified":"2026-08-24T08:31:11+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/"},"wordCount":100,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/08\/Summary-report-on-EARS-Net-EQA-2025.png","keywords":["AMR","Antibior\u00e9sistance","Antibiotic Resistance","antimicrobial","Antimicrobial Resistance"],"articleSection":["Actualit\u00e9s","Bilans, rapports et recommandations","Infos pratiques &amp; communications"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/","name":"Rapport de synth\u00e8se sur l\u2019EQA 2025 de l\u2019EARS-Net - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/08\/Summary-report-on-EARS-Net-EQA-2025.png","datePublished":"2026-08-24T08:30:28+00:00","dateModified":"2026-08-24T08:31:11+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/08\/Summary-report-on-EARS-Net-EQA-2025.png","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2026\/08\/Summary-report-on-EARS-Net-EQA-2025.png","width":629,"height":848},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapport-de-synthese-sur-leqa-2025-de-lears-net\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/"},{"@type":"ListItem","position":4,"name":"Rapport de synth\u00e8se sur l\u2019EQA 2025 de l\u2019EARS-Net"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6d6eef4984fc1159096f6dd1f6c2ac41","name":"Aurore Brunet"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-08-31 12:50:47","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/31460"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/285"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=31460"}],"version-history":[{"count":3,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/31460\/revisions"}],"predecessor-version":[{"id":31465,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/31460\/revisions\/31465"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media\/31461"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=31460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=31460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=31460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}